All MOTS-c certificates

MOTS-c 5 mg Certificate of Analysis Batch APL-MOTS5-2607-02

MOTS-c 5 mg from batch APL-MOTS5-2607-02 was analysed on 22 July 2026 and measured 99.03% purity by HPLC / Mass Spectrometry, passing all 5 release tests.

Purity
99.03%
Result
All 5 tests passed
Tested
22 July 2026
Method
HPLC / Mass Spectrometry
Net content
5.10 mg

Independent verification

MOTS-c 5 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 98.59% purity by UPLC-MS/MS, analysed 29 August 2026 on lot APL-MOTS10-2608-01, net content 9.80 mg, verification code OZ-HPLCMS-TS08; bacterial endotoxin below 15.0 EU per vial by kinetic chromogenic LAL, analysed 30 August 2026, verification code OZ-ENDOTX-TAU5.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 2

Certificate of Analysis MOTS-c 5 mg Batch APL-MOTS5-2607-02
Compound
MOTS-c
Lot Number
APL-MOTS5-2607-02
Analysis Date
22 July 2026
Method
HPLC / Mass Spectrometry
Purity
99.03%
Net Content
5.10 mg
MOTS-c vial
CAS Number
1627580-64-6
Formula
C101H152N28O22S2
Molecular Weight
2174.6 g/mol
Form
Lyophilised Powder
Manufactured
July 2026
Issued
23 July 2026
Document ID
APL-COA-MOTS5-2607-02
Verification Code
Batch traceable
SequenceMRWQEMGYIFYPRKLR

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm0375750112515003.544.555.566.57 min 4.2294.4524.593MOTS-c5.0736.182

Main peak integrated at 99.03% of total area; no single impurity peak exceeds 0.32%.

Peak List

Peaks detected: 5
#Time (min)Area% AreaIdentification
14.22915,8740.220—
24.45223,3900.320—
34.5937,268,01499.030MOTS-c
45.07318,0310.250—
56.18213,3480.180—

Analytical Results

TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)ConfirmedConfirmedPASS
Purity (HPLC)≥98.0%99.03%PASS
Peptide Content95–105%98.8%PASS
Endotoxins<0.5 EU/mg<0.10 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 2

MOTS-c 5 mg

CAS Number: 1627580-64-6

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 22 July 2026
Monitored (m/z)Detected (m/z)Relative Intensity
545544.641.23
726725.842.34
10881088.31.79

Detection assignment: MOTS-c

Collected Mass Spectrum

Intensity ×107

0123200400600800100012001400 m/z 5457261088

Verification Protocol

  • Identity confirmed by mass spectrometry against the expected ion channels.
  • Purity measured by HPLC as peak area against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View MOTS-c in the catalogueHow to read this certificate